Eventide Asset Management - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q4 2014$1,123,000
+7.2%
30,0000.0%0.12%
-15.8%
Q3 2014$1,048,000
-25.0%
30,0000.0%0.15%
-23.2%
Q2 2014$1,397,000
-33.3%
30,000
-55.8%
0.19%
-41.5%
Q1 2014$2,094,000
+208.8%
67,800
+129.1%
0.32%
+55.5%
Q4 2013$678,00029,6000.21%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders